Cannabis and antibiotics could be a successful combination against bacteria

Finding alternative solutions to fight bacteria is a difficult but not impossible task. As antibiotics effectiveness keeps going down, scientists are researching the potential of cannabis and its possible applications in the medical field. Currently, the University of Southern Denmark is focusing on how cannabis can be used together with some known antibiotics to boost their effect.

At the end of February, news of a study started to circulate. A research report that detailed investigations into the ability of cannabigerol to combat multi-resistant germs was released.

Clinical trials conducted by McMaster University in Canada demonstrated that the special cannabinoid cannabigerol (CBG), in combination with the drug polymyxin B, is effective against multi-resistant Gram-negative pathogens.

A similar study has been conducted that concentrated on cannabidiol and its influence on antibiotics. The results of the research showed that cannabidiol (CBD) supports the effect of antibiotics!

If you want to find out how cannabis can effectively combat multi-resistant germs, how this plant can be used in the treatment of many diseases and ailments, how the University of Southern Denmark is focusing its research on understanding the properties of cannabis, and to find out the latest cannabis news, download the Hemp.im mobile application.

Unlocking the supportive properties of cannabis could lead to new treatments

As reported by Business Insider, scientists at the University of Southern Denmark have focused their research on the supportive properties of cannabidiol on antibiotics. It was proven that cannabidiol enhances the effectiveness of the drugs used.

If cannabidiol is used together with antibiotics in the fight against multi-resistant pathogens, the dose of antibiotics can be reduced, which has several advantages. Since the treatment of infections with multi-resistant germs is already increasing and will probably continue to increase in the future, and is becoming more and more difficult to control, research is concentrating on so-called helper substances that enhance the effect of the antibiotic without having to resort to higher doses of the drug actually used.

According to the results of the researchers at the University of Southern Denmark, cannabidiol (CBD) is just what is needed. The natural substance extracted from cannabis, according to the researchers, strengthens the effect of the antibiotic and, when used together with it, can kill more bacteria than the antibiotic alone.

The fight between antibiotics and bacteria is getting tougher

The antibiotic bacitracin was used in the fight against Staphylococcus aureus bacteria, which causes pneumonia and meningitis, among other diseases. Several variations of these bacteria are already resistant to the usual treatment methods with common antibiotics, so alternatives must be urgently found.

The experiment has now shown that cannabidiol in combination with antibiotics has a strengthening effect, so that a higher success against the pathogens could be achieved without having to increase the administration of the antibiotic.

This is also a great advantage because it prevents even more germs from developing resistance to antibiotics. Researchers observed that the normal division of the staphylococcus bacteria was prevented and that the bacterial membrane developed instabilities.

Cannabis in conjunction with other antibiotics could be a powerful option

Based on these observations, scientists suggested in their research summary that the combination of cannabidiol and bacitracin may represent a potential novel treatment in clinical settings for the treatment of infections with antibiotic-resistant, Gram-positive bacteria.

Thus cannabidiol (CBD) not only directly helps patients infected with antibiotic-resistant bacteria, but can also help to reduce the number of such dangerous hospital germs that develop in the first place.

__

(Featured image by Michael Moriarty via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Hanf Journal, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.